Chan K - Search Results

1

Economic evaluation of smoking cessation in Ontario's regional cancer programs.

Djalalov S, Masucci L, Isaranuwatchai W, Evans W, Peter A, Truscott R, Cameron E, Mittmann N, Rabeneck L, Chan K, Hoch JS. Djalalov S, et al. Among authors: chan k. Cancer Med. 2018 Sep;7(9):4765-4772. doi: 10.1002/cam4.1495. Epub 2018 Jul 17. Cancer Med. 2018. PMID: 30019421 Free PMC article.

2

Cost-effectiveness of systemic therapies for metastatic pancreatic cancer.

Tam VC, Ko YJ, Mittmann N, Cheung MC, Kumar K, Hassan S, Chan KK. Tam VC, et al. Among authors: chan kk. Curr Oncol. 2013 Apr;20(2):e90-e106. doi: 10.3747/co.20.1223. Curr Oncol. 2013. PMID: 23559890 Free PMC article.

3

Genomic testing in cancer: patient knowledge, attitudes, and expectations.

Blanchette PS, Spreafico A, Miller FA, Chan K, Bytautas J, Kang S, Bedard PL, Eisen A, Potanina L, Holland J, Kamel-Reid S, McPherson JD, Razak AR, Siu LL. Blanchette PS, et al. Among authors: chan k. Cancer. 2014 Oct 1;120(19):3066-73. doi: 10.1002/cncr.28807. Epub 2014 Jun 24. Cancer. 2014. PMID: 24962202 Free article.

4

Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study.

de Oliveira C, Bremner KE, Pataky R, Gunraj N, Haq M, Chan K, Cheung WY, Hoch JS, Peacock S, Krahn MD. de Oliveira C, et al. Among authors: chan k. CMAJ Open. 2013 Dec 9;1(4):E151-8. doi: 10.9778/cmajo.20130041. eCollection 2013 Oct. CMAJ Open. 2013. PMID: 25077117 Free PMC article.

5

Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D.

Lee EK, Wong WW, Trudeau ME, Chan KK. Lee EK, et al. Among authors: chan kk. Breast Cancer Res Treat. 2015 Feb;150(1):169-80. doi: 10.1007/s10549-015-3309-3. Epub 2015 Feb 19. Breast Cancer Res Treat. 2015. PMID: 25694355

6

Frontline rituximab monotherapy induction versus a watch and wait approach for asymptomatic advanced-stage follicular lymphoma: A cost-effectiveness analysis.

Prica A, Chan K, Cheung M. Prica A, et al. Among authors: chan k. Cancer. 2015 Aug 1;121(15):2637-45. doi: 10.1002/cncr.29372. Epub 2015 Apr 15. Cancer. 2015. PMID: 25877511 Free article.

7

Adjuvant taxane-based chemotherapy for early stage breast cancer: a real-world comparison of chemotherapy regimens in Ontario.

Torres S, Trudeau M, Eisen A, Earle CC, Chan KKW. Torres S, et al. Among authors: chan kkw. Breast Cancer Res Treat. 2015 Jul;152(1):137-145. doi: 10.1007/s10549-015-3441-0. Epub 2015 May 31. Breast Cancer Res Treat. 2015. PMID: 26026467

8

Adjusting for Drug Wastage in Economic Evaluations of New Therapies for Hematologic Malignancies: A Systematic Review.

Lien K, Cheung MC, Chan KK. Lien K, et al. Among authors: chan kk. J Oncol Pract. 2016 Apr;12(4):e369-79. doi: 10.1200/JOP.2015.005876. Epub 2015 Sep 1. J Oncol Pract. 2016. PMID: 26330534 Review.

9

Associations among socioeconomic status, patterns of care and outcomes in breast cancer patients in a universal health care system: Ontario's experience.

Kumachev A, Trudeau ME, Chan KK. Kumachev A, et al. Among authors: chan kk. Cancer. 2016 Mar 15;122(6):893-8. doi: 10.1002/cncr.29838. Epub 2015 Dec 22. Cancer. 2016. PMID: 26696022 Free article.

10

Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancer.

Lien K, Tam VC, Ko YJ, Mittmann N, Cheung MC, Chan KK. Lien K, et al. Among authors: chan kk. Curr Oncol. 2015 Dec;22(6):e443-52. doi: 10.3747/co.22.2592. Curr Oncol. 2015. PMID: 26715881 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12,252 results

Search Page